Marijuana Considered for Looser Restrictions by U.S. FDA
U.S. regulators are studying whether restrictions on marijuana should be eased, a step toward decriminalizing the drug at the federal level. The Food and Drug Administration is conducting an analysis at the Drug Enforcement Administration’s request on whether the U.S. should downgrade the classification of marijuana as a Schedule 1 drug, said Douglas Throckmorton, Deputy Director for Regulatory Programs at the FDA, at a congressional hearing. Schedule 1 drugs carry the most restrictions of the five DEA classifications and are [...]
